Patents Assigned to Arbor Biotechnologies, Inc.
  • Patent number: 10392616
    Abstract: The disclosure describes novel systems, methods, and compositions for the manipulation of nucleic acids in a targeted fashion. The disclosure describes non-naturally occurring, engineered CRISPR systems, components, and methods for targeted modification of a nucleic acid.
    Type: Grant
    Filed: March 8, 2018
    Date of Patent: August 27, 2019
    Assignee: Arbor Biotechnologies, Inc.
    Inventors: David R. Cheng, David A. Scott, Winston X. Yan, Shaorong Chong